• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于抗肿瘤药物的钌-芳烃配合物的设计

Design of Ru-arene Complexes for Antitumor Drugs.

作者信息

Su Wei, Li Yuchun, Li Peiyuan

机构信息

Department of Chemistry, Guangxi Teachers Education University, Nanning. China.

College of Pharmacy, Guangxi University of Chinese Medicine, Nanning 530000. China.

出版信息

Mini Rev Med Chem. 2018;18(2):184-193. doi: 10.2174/1389557517666170510113453.

DOI:10.2174/1389557517666170510113453
PMID:28494728
Abstract

Recently, a number of promising ruthenium complexes have been investigated as anticancer drugs. Ru-arene complexes with [(η6-arene)Ru(X)(Y)(Z)] type, which exhibit a great structural variety, offer much potential in drug design. In this review we provide an overview of the progress in the field of arene ruthenium chemistry. We focus our attention particularly on the molecular structures and the anticancer applications of the Ru-arene complexes. Recent developments in the chemistry of arene ruthenium complexes will provide information for the investigation of novel anticancer organometallic drugs.

摘要

最近,一些有前景的钌配合物作为抗癌药物受到了研究。具有[(η6-芳烃)Ru(X)(Y)(Z)]类型的钌-芳烃配合物结构多样,在药物设计方面具有很大潜力。在本综述中,我们概述了芳烃钌化学领域的进展。我们特别关注钌-芳烃配合物的分子结构和抗癌应用。芳烃钌配合物化学的最新进展将为新型抗癌有机金属药物的研究提供信息。

相似文献

1
Design of Ru-arene Complexes for Antitumor Drugs.用于抗肿瘤药物的钌-芳烃配合物的设计
Mini Rev Med Chem. 2018;18(2):184-193. doi: 10.2174/1389557517666170510113453.
2
Arene ruthenium complexes as anticancer agents.钌芳配合物作为抗癌剂。
Dalton Trans. 2010 Feb 21;39(7):1673-88. doi: 10.1039/b916860p. Epub 2009 Oct 23.
3
Dimetallic Ru(II) arene complexes appended on bis-salicylaldimine induce cancer cell death and suppress invasion via p53-dependent signaling.双水杨醛亚胺负载的二金属钌(II)芳基金属配合物通过依赖 p53 的信号通路诱导癌细胞死亡和抑制侵袭。
Eur J Med Chem. 2018 Sep 5;157:1480-1490. doi: 10.1016/j.ejmech.2018.08.054. Epub 2018 Aug 21.
4
Organometallic chemistry, biology and medicine: ruthenium arene anticancer complexes.有机金属化学、生物学与医学:钌芳烃抗癌配合物
Chem Commun (Camb). 2005 Oct 14(38):4764-76. doi: 10.1039/b508531b. Epub 2005 Aug 26.
5
Derivation of structure-activity relationships from the anticancer properties of ruthenium(II) arene complexes with 2-aryldiazole ligands.基于钌(II)芳烃配合物与2-芳基二唑配体的抗癌特性推导构效关系
Inorg Chem. 2014 Oct 20;53(20):11274-88. doi: 10.1021/ic501865h. Epub 2014 Oct 10.
6
Arene Ruthenium(II) Complexes with Phosphorous Ligands as Possible Anticancer Agents.作为潜在抗癌剂的含磷配体芳基钌(II)配合物
Chimia (Aarau). 2017 Sep 27;71(9):573-579. doi: 10.2533/chimia.2017.573.
7
A novel ruthenium(II) arene based intercalator with potent anticancer activity.一种具有强大抗癌活性的新型钌(II)芳烃基嵌入剂。
Dalton Trans. 2009 Jul 14(26):5071-3. doi: 10.1039/b907296a. Epub 2009 May 12.
8
Synthesis and cytotoxic activities of organometallic Ru(II) diamine complexes.有机金属 Ru(II) 二胺配合物的合成及细胞毒性活性。
Bioorg Chem. 2020 Jun;99:103793. doi: 10.1016/j.bioorg.2020.103793. Epub 2020 Apr 4.
9
Development of organometallic ruthenium-arene anticancer drugs that resist hydrolysis.抗水解的有机金属钌-芳烃抗癌药物的研发。
Inorg Chem. 2006 Oct 30;45(22):9006-13. doi: 10.1021/ic061008y.
10
Dual-targeting organometallic ruthenium(II) anticancer complexes bearing EGFR-inhibiting 4-anilinoquinazoline ligands.带有抑制表皮生长因子受体(EGFR)的4-苯胺基喹唑啉配体的双靶向有机金属钌(II)抗癌配合物
Dalton Trans. 2015 Aug 7;44(29):13100-11. doi: 10.1039/c5dt01430a.

引用本文的文献

1
Synthesis and Antiparasitic Activity of New Trithiolato-Bridged Dinuclear Ruthenium(II)-arene-carbohydrate Conjugates.新型三硫代桥联双核钌(II)-芳基-碳水化合物轭合物的合成及抗寄生虫活性。
Molecules. 2023 Jan 16;28(2):902. doi: 10.3390/molecules28020902.
2
Safety and Efficacy Evaluation In Vivo of a Cationic Nucleolipid Nanosystem for the Nanodelivery of a Ruthenium(III) Complex with Superior Anticancer Bioactivity.用于具有优异抗癌生物活性的钌(III)配合物纳米递送的阳离子核脂质纳米系统的体内安全性和有效性评估
Cancers (Basel). 2021 Oct 14;13(20):5164. doi: 10.3390/cancers13205164.
3
Piano-Stool Ruthenium(II) Complexes with Delayed Cytotoxic Activity: Origin of the Lag Time.
具有迟滞细胞毒性活性的钢琴凳钌(II)配合物:滞后时间的起源。
Inorg Chem. 2021 Jun 7;60(11):7974-7990. doi: 10.1021/acs.inorgchem.1c00507. Epub 2021 May 12.
4
Recent Advances in the Biological Investigation of Organometallic Platinum-Group Metal (Ir, Ru, Rh, Os, Pd, Pt) Complexes as Antimalarial Agents.新型有机金属铂族金属(Ir、Ru、Rh、Os、Pd、Pt)配合物作为抗疟药物的生物学研究进展。
Molecules. 2020 Nov 12;25(22):5276. doi: 10.3390/molecules25225276.
5
Zinc-Containing Metalloenzymes: Inhibition by Metal-Based Anticancer Agents.含锌金属酶:金属基抗癌剂的抑制作用
Front Chem. 2020 May 19;8:402. doi: 10.3389/fchem.2020.00402. eCollection 2020.